Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Attal

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Annales Pharmaceutiques Francaises|May 3, 2000
[Recent pharmacologic approaches to pain]N Attal, D Bouhassira
Presse Medicale (Paris, France : 1983)|October 22, 1988
[Analgesic action of sodium diclofenac: behavioral and electrophysiological study in normal and polyarthritic rats]N Attal, G Guilbaud
Acta Neurologica Scandinavica. Supplementum|May 20, 2000
Mechanisms of pain in peripheral neuropathyN Attal, D Bouhassira
Toxicon : Official Journal of the International Society on Toxinology|June 29, 2023
Botulinum toxin A and neuropathic pain: An updateA Spagna, N Attal
Revue Neurologique|August 1, 2021
French guidelines for neuropathic pain: An update and commentaryX Moisset, D Bouhassira, N Attal
Brain Research|August 13, 1990
The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: a study in a rat model of peripheral mononeuropathyN Attal, V Kayser, G Guilbaud
Brain Research|November 29, 1991
Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in rats with a peripheral neuropathyA Neil, N Attal, G Guilbaud
European Journal of Pain (London, England)|May 31, 2013
Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort studyF Radat, A Margot-Duclot, N Attal
Progress in Clinical and Biological Research|January 1, 1990
Naloxone induces a bidirectional effect on phasic and "spontaneous" pain-related behaviour in rats with a peripheral mononeuropathyF Jazat, N Attal, V Kayser, et al.
Pain|January 1, 1993
Are mechanical and cold allodynia in mononeuropathic and arthritic rats relieved by systemic treatment with calcitonin or guanethidine?S Perrot, N Attal, D Ardid, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Annales Pharmaceutiques Francaises|May 3, 2000
[Recent pharmacologic approaches to pain]N Attal, D Bouhassira
Presse Medicale (Paris, France : 1983)|October 22, 1988
[Analgesic action of sodium diclofenac: behavioral and electrophysiological study in normal and polyarthritic rats]N Attal, G Guilbaud
Acta Neurologica Scandinavica. Supplementum|May 20, 2000
Mechanisms of pain in peripheral neuropathyN Attal, D Bouhassira
Toxicon : Official Journal of the International Society on Toxinology|June 29, 2023
Botulinum toxin A and neuropathic pain: An updateA Spagna, N Attal
Revue Neurologique|August 1, 2021
French guidelines for neuropathic pain: An update and commentaryX Moisset, D Bouhassira, N Attal
Brain Research|August 13, 1990
The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: a study in a rat model of peripheral mononeuropathyN Attal, V Kayser, G Guilbaud
Brain Research|November 29, 1991
Effects of guanethidine on sensitization to natural stimuli and self-mutilating behaviour in rats with a peripheral neuropathyA Neil, N Attal, G Guilbaud
European Journal of Pain (London, England)|May 31, 2013
Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort studyF Radat, A Margot-Duclot, N Attal
Progress in Clinical and Biological Research|January 1, 1990
Naloxone induces a bidirectional effect on phasic and "spontaneous" pain-related behaviour in rats with a peripheral mononeuropathyF Jazat, N Attal, V Kayser, et al.
Pain|January 1, 1993
Are mechanical and cold allodynia in mononeuropathic and arthritic rats relieved by systemic treatment with calcitonin or guanethidine?S Perrot, N Attal, D Ardid, et al.
Pageof 7